daunorubicin has been researched along with Waldenstrom Macroglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doria, G; Franchi, F; Konovalova, N; Pioli, C; Rossetti, R; Rossi Fanelli, F; Seminara, P; Tubani, L | 1 |
| Bile, G; De Biasi, R | 1 |
1 trial(s) available for daunorubicin and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders.
Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia | 2001 |
1 other study(ies) available for daunorubicin and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
[Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms].
Topics: Daunorubicin; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia | 1969 |